Abstract
Background
By inhibiting the growth of pathogenic bacteria and modulating the local intestinal immune system, probiotics may reduce bacterial translocation and systemic endotoxaemia, factors partially responsible for post-operative complications following liver resection for hepatocellular carcinoma in patients with cirrhosis.
Methods
Patients with resectable hepatocellular carcinoma developed in the setting of chronic liver disease were prospectively divided into two equal-sized groups: one receiving probiotic treatment 14 days prior to surgery and the other receiving placebo. The primary endpoint was the level of circulating endotoxins after hepatectomy. Secondary endpoints were systemic inflammation (inflammatory cytokine levels), post-operative liver function and overall post-operative complication rate.
Results
From May 2013 to December 2018, 64 patients were randomized, and 54 patients were included in the analysis, 27 in each arm. No significant change in endotoxin levels was observed over time in either group (P = 0.299). No difference between the groups in terms of post-operative liver function and overall complication rates was observed. The only differences observed were significant increases in the levels of TNFalpha (P = 0.019) and interleukin 1-b (P = 0.028) in the probiotic group in the post-operative period.
Conclusion
Contrary to the modest data reported in the literature, the administration of probiotics before minor liver resection for hepatocellular carcinoma developed in the setting of compensated chronic liver disease does not seem to have an impact on circulating endotoxin levels or post-operative complication rates.
Trial registration
Trial registration: NCT02021253.
Similar content being viewed by others
Change history
15 December 2021
A Correction to this paper has been published: https://doi.org/10.1007/s00268-021-06411-x
Abbreviations
- ASA:
-
American Society of Anesthesiologists
- AUC:
-
Area under the curve
- HCC:
-
Hepatocellular carcinoma
- LAL:
-
Limulus amoebocyte lysate
- LPS:
-
Lipopolysaccharide
References
Filmann N, Walter D, Schadde E et al (2019) Mortality after liver surgery in Germany. Br J Surg 106(11):1523–1529
Cirera I, Bauer TM, Navasa M et al (2001) Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 34:32
Yeh D-C, Wu C-C, Ho W-M et al (2003) Bacterial translocation after cirrhotic liver resection: a clinical investigation of 181 patients. J Surg Res 111(2):209–214
Fukui H (2015) Gut-liver axis in liver cirrhosis: how to manage leaky gut and endotoxemia. WJH 7(3):425
Stoclet JC, Fleming I, Gray G et al (1993) Nitric oxide and endotoxemia. Circulation 87(SUPPL V):V77–V80
Sogni P, Moreau R, Lebrec D (1999) Endotoxemia: an unnecessary but aggravating condition in portal hypertension? J Hepatol 30(6):1160–1162
Lin CY, Tsai IF, Ho YP et al (2007) Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol 46(5):816–826
Stadlbauer V, Davies NA, Wright GA et al (2007) Endotoxemia during liver transplantation. Liver Transpl 13(11):1616–1617
Nakagawa K, Matsubara S, Ouchi K, Owada Y, Yajima Y (1986) Endotoxemia after abdominal surgery. Tohoku J Exp Med 150(3):273–280
Nakagawa K, Ouchi K, Matsubara S et al (1987) Activation of reticuloendothelial function for prevention of endotoxemia after hepatectomy in cirrhotic patients. Tohoku J Exp Med 153(2):133–136
Nolan JP (2010) The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology 52(5):1829–1835
Qin N, Yang F, Li A et al (2014) Alterations of the human gut microbiome in liver cirrhosis. Nature 513(7516):59–64
Chen Y, Yang F, Lu H et al (2011) Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54(2):562–572
Hill C, Guarner F, Reid G et al (2014) The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11(8):506–514
Bongaerts GPA, Severijnen RSVM (2016) A reassessment of the PROPATRIA study and its implications for probiotic therapy. Nat Biotechnol 34(1):55–63
Saab S, Suraweera D, Au J, Saab EG, Alper TS, Tong MJ (2016) Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials. Liver Int 36(7):986–993
Dhiman RK, Rana B, Agrawal S et al (2014) Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. Gastroenterology 147(6):1327-1337.e3
Bajaj JS, Heuman DM, Hylemon PB et al (2014) Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol Ther 39(10):1113–1125
Rayes N, Pilarski T, Stockmann M, Bengmark S, Neuhaus P, Seehofer D (2012) Effect of pre- and probiotics on liver regeneration after resection: a randomised, double-blind pilot study. Benef Microbes 3(3):237–244
Iida H, Sasaki M, Maehira H et al (2020) The effect of preoperative synbiotic treatment to prevent surgical-site infection in hepatic resection. J Clin Biochem Nutr 66(1):67–73
Grąt M, Wronka KM, Lewandowski Z et al (2017) Effects of continuous use of probiotics before liver transplantation: a randomized, double-blind, placebo-controlled trial. Clin Nutr 36(6):1530–1539
Ray S, Mehta NN, Golhar A, Nundy S (2018) Post hepatectomy liver failure—a comprehensive review of current concepts and controversies. Ann Med Surg (Lond) 34:4–10
Trebicka J, Krag A, Gansweid S et al (2011) Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol 23(12):1218–1225
Sugawara G, Nagino M, Nishio H et al (2006) Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg 244(5):706–714
Rayes N, Seehofer D, Theruvath T et al (2005) Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation-a randomized, Double-Blind Trial. Am J Transplant 5(1):125–130
Coltart I, Tranah TH, Shawcross DL (2013) Inflammation and hepatic encephalopathy. Arch Biochem Biophys 536(2):189–196
Violi F, Ferro D, Basili S et al (1995) Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 109(2):531–539
Lata J, Novotný I, Příbramská V et al (2007) The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study. Eur J Gastroenterol Hepatol 19(12):1111–1113
Chu CJ, Lee FY, Wang SS et al (1997) Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor-alpha and nitric oxide. Clin Sci 93(3):219–225
Guarner C, Soriano G, Tomas A et al (1993) Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 18(5):1139–1143
López-Collazo E, del Fresno C (2013) Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences. Crit Care 17(6):242
Draisma A, Pickkers P, Bouw MPWJM, van der Hoeven JG (2009) Development of endotoxin tolerance in humans in vivo. Crit Care Med 37(4):1261–1267
Liu Z, Li C, Huang M et al (2015) Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial. BMC Gastroenterol 15(1):34
Melloul E, Hübner M, Scott M et al (2016) Guidelines for perioperative care for liver surgery: enhanced recovery after surgery (ERAS) Society Recommendations. World J Surg 40(10):2425–2440
Kanazawa H, Nagino M, Kamiya S et al (2005) Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 390(2):104–113
Eguchi S, Takatsuki M, Hidaka M, Soyama A, Ichikawa T, Kanematsu T (2011) Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. Am J Surg 201(4):498–502
Wu X-D, Liu M-M, Liang X, Hu N, Huang W (2018) Effects of perioperative supplementation with pro-/synbiotics on clinical outcomes in surgical patients: a meta-analysis with trial sequential analysis of randomized controlled trials. Clin Nutr 37(2):505–515
Chowdhury AH, Adiamah A, Kushairi A et al (2019) Perioperative probiotics or synbiotics in adults undergoing elective abdominal surgery: a systematic review and meta-analysis of randomized controlled trials. Ann Surg 31:112
Pereg D, Kotliroff A, Gadoth N, Hadary R, Lishner M, Kitay-Cohen Y (2011) Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study. Nutrition 27(2):177–181
Horvath A, Leber B, Schmerboeck B et al (2016) Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Aliment Pharmacol Ther 44(9):926–935
Zmora N, Zilberman-Schapira G, Suez J et al (2018) Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174(6):1388-1405.e21
Schwenger KJ, Clermont-Dejean N, Allard JP (2019) The role of the gut microbiome in chronic liver disease: the clinical evidence revised. JHEP Rep 1(3):214–226
Bauer TM, Fernández J, Navasa M, Vila J, Rodés J (2002) Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis. J Hepatol 36(4):501–506
Gnauck A, Lentle RG, Kruger MC (2016) Chasing a ghost? Issues with the determination of circulating levels of endotoxin in human blood. Crit Rev Clin Lab Sci 53(3):197–215
Munford RS (2016) Endotoxemia—menace, marker, or mistake? J Leukoc Biol 100(4):687–698
Acknowledgements
We thank Valentin Harter, from the department of data management -Cancéropôle Nord-Ouest—for assistance with the statistical analysis.
Funding
No financial support.
Author information
Authors and Affiliations
Contributions
Conception and design of the study: CBL, JJT, HM, PT, SB, LS. Acquisition, analysis and interpretation of the data: ER, CBL, JJT, HM, EP, PT, SB, LS. Drafting the article: ER, EP, LS. Revising the article critically for important intellectual content: ER, CBL, JJT, HM, EP, PT, SB, LS.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: The authors' names were corrected.
Rights and permissions
About this article
Cite this article
Roussel, E., Brasse-Lagnel, C., Tuech, JJ. et al. Influence of Probiotics Administration Before Liver Resection in Patients with Liver Disease: A Randomized Controlled Trial. World J Surg 46, 656–665 (2022). https://doi.org/10.1007/s00268-021-06388-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-021-06388-7